26.12.2014 Views

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

IV. Specific Enzymes<br />

359<br />

GGT is a membrane-bound enzyme on the external surface<br />

<strong>of</strong> cells and is bound to the cell membrane via a hydrophobic<br />

transmembrane peptide. The cellular location <strong>of</strong> GGT<br />

is <strong>of</strong> interest as it affects the organ specificity when used as<br />

a diagnostic test in serum. GGT is located on the luminal<br />

surface <strong>of</strong> the proximal tubular cells <strong>of</strong> the kidney where<br />

it is shed into urine during tubular injury. In the pancreas,<br />

GGT is located on the luminal surface <strong>of</strong> cells lining the<br />

acini and pancreatic ducts. Increases <strong>of</strong> serum GGT activity<br />

are not generally associated with injury to the pancreas<br />

or kidney. The location <strong>of</strong> GGT in liver is <strong>of</strong> considerable<br />

interest because the liver likely contributes most if not all<br />

<strong>of</strong> the serum GGT activity. In liver, GGT activity is primarily<br />

associated with the biliary epithelial cells. Early reports<br />

suggested GGT was not present on hepatocyte membranes;<br />

however, when GSH was used in the fixative solution to<br />

prevent fixation-induced inhibition <strong>of</strong> GGT activity, GGT<br />

activity was identified on both the canalicular and sinusoidal<br />

surfaces <strong>of</strong> hepatocytes <strong>of</strong> rats, although to a considerably<br />

lesser extent than on biliary epithelial cells ( Lanca and Israel,<br />

1991 ). GGT mRNA has been detected in hepatocytes <strong>of</strong> normal<br />

rats and rats depleted <strong>of</strong> glutathione, supporting the presence<br />

<strong>of</strong> GGT on hepatocytes ( Moriya et al. , 1994 ). Whether<br />

GGT activity is present on the hepatocyte membranes<br />

<strong>of</strong> domestic animals is not documented to our knowledge.<br />

Efforts have been made to determine the presence <strong>of</strong><br />

isoenzymes <strong>of</strong> GGT in laboratory animals and humans, but<br />

it is likely that only one form <strong>of</strong> GGT exists. Variations in<br />

sialic acid content have been reported and likely explain<br />

the ability to separate different fractions <strong>of</strong> GGT by various<br />

means, such as isoelectric focusing ( Mortensen and<br />

Huseby, 1997 ). Only one band <strong>of</strong> GGT activity was found<br />

with cellulose acetate electrophoresis <strong>of</strong> serum from dogs<br />

( Milne and Doxey, 1985 ).<br />

Removal <strong>of</strong> GGT activity from blood likely involves<br />

endocytosis by the asialoglycoprotein or galactose receptor,<br />

as purified human liver GGT that has been fractionated<br />

by ion exchange chromatography and infused into rats has<br />

shown that the slowest rate <strong>of</strong> clearance is associated with<br />

the most sialated forms (Morensen and Huseby, 1997).<br />

Clearance can be blocked with asial<strong>of</strong>etuin, also suggesting<br />

that clearance <strong>of</strong> GGT is via the asialoglycoprotein or galactose<br />

receptor on hepatocytes. GGT is apparently eliminated<br />

from blood without prior desialylation via exposed galactose<br />

units binding with low affinity to the receptor. The rate <strong>of</strong><br />

removal <strong>of</strong> each molecule may be related to the number <strong>of</strong><br />

available galactose molecules not blocked by sialic acid.<br />

The half-life <strong>of</strong> GGT activity in blood is not known,<br />

as there have been no definitive studies done in domestic<br />

animals to our knowledge. However, in dogs, serum GGT<br />

and ALP activity increase and decrease in parallel during<br />

cholestasis, suggesting that in dogs the half-life <strong>of</strong> GGT<br />

may be similar to the approximate 3-day half-life <strong>of</strong> liver<br />

ALP. A half-life <strong>of</strong> 3 days is also suggested for GGT activity<br />

in horses ( Barton and Morris, 1998 ). In any event, the<br />

half-life <strong>of</strong> liver GGT activity is <strong>of</strong> sufficient length that<br />

increases are maintained throughout the disease process<br />

and diagnostic sensitivity is not lost because <strong>of</strong> a rapid<br />

return <strong>of</strong> the GGT activity to reference ranges.<br />

Conditions such as hepatic necrosis and reversible hepatocellular<br />

injury induced by CCl 4 , dibromobenzene, chlor<strong>of</strong>orm<br />

toxicity, and trauma result in minimal or no changes in<br />

serum GGT activity in dogs ( Barakat and Ford, 1988 ; Guelfi<br />

et al. , 1982 ; Noonan and Meyer, 1979 ). However, some<br />

increase in serum GGT activity is observed with chlor<strong>of</strong>orm<br />

toxicity in horses, although no increase is observed in calves<br />

and sheep ( Barakat and Ford, 1988 ). Following administration<br />

<strong>of</strong> CCl 4 to ponies, a four-fold increase in serum GGT<br />

activity was observed, which persisted up to 10 days with no<br />

increase in serum ALP activity ( H<strong>of</strong>fmann et al. , 1987 ). The<br />

minimal increase in GGT activity in serum following hepatocellular<br />

injury is likely due to the fact that GGT in liver<br />

is primarily associated with biliary epithelial cells and the<br />

absence <strong>of</strong> significant increase <strong>of</strong> bile acids to release the<br />

hydrophobic transmembrane attachment to the cell membrane.<br />

Increases in serum GGT are most <strong>of</strong>ten observed with<br />

cholestasis and conditions resulting in biliary hyperplasia in<br />

all species, as observed in experimentally induced cholestasis<br />

(DeNovo and Prasse, 1983; H<strong>of</strong>fmann et al. , 1987 ; Shull<br />

and Hornbuckle, 1979 ; Spano et al. , 1983 ).<br />

Serum GGT activity is an especially useful clinical indicator<br />

<strong>of</strong> cholestasis in horses and cattle because <strong>of</strong> relatively<br />

high liver GGT activity compared to dogs and cats. Serum<br />

GGT activity in horses and cattle has relatively higher sensitivity<br />

for the identification <strong>of</strong> cholestatic disorders than serum<br />

ALP activity. Only a two-fold increase <strong>of</strong> serum ALP activity<br />

was observed with cholestasis, whereas serum GGT activity<br />

rose nine-fold in horses ( H<strong>of</strong>fmann et al. , 1987 ). Although<br />

the magnitude <strong>of</strong> increase is greatest in cholestasis, serum<br />

GGT activity can be used in large animals as a screening<br />

test for generalized hepatic disease as well. In a retrospective<br />

study <strong>of</strong> 50 cases <strong>of</strong> hepatic disease in horses, <strong>of</strong> the serum<br />

chemistry parameters evaluated only serum GGT activity<br />

increased in all cases ( McGorum et al. , 1999 ). Similarly,<br />

serum GGT activity showed 75% sensitivity and 90% specificity<br />

for detecting subclinical liver disease in horses exposed<br />

to pyrrolizidine alkaloids, whereas serum ALP activity<br />

showed only 58% sensitivity ( Curran et al. , 1996 ). Serum<br />

GGT activity was shown to be the most sensitive serum<br />

enzyme for detection <strong>of</strong> hepatic injury secondary to proximal<br />

enteritis in horses ( Davis et al. , 2003 ). Increases in serum<br />

GGT activity in numerous cases <strong>of</strong> plant-related hepatotoxicity<br />

in both cattle and horses have also been reported ( Craig<br />

et al. , 1991 ; Curran et al. , 1996 ; Mendel et al. , 1988 ) .<br />

Serum GGT activity in cats and dogs is <strong>of</strong>ten interpreted<br />

in conjunction with serum ALP activity. The suggested<br />

advantage <strong>of</strong> serum GGT activity determination<br />

over serum ALP activity in dogs is increased specificity, as<br />

GGT activity is derived solely from liver whereas serum<br />

ALP activity is derived from bone and liver as well as the

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!